Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.

Frodlund M, Wetterö J, Dahle C, Dahlström Ö, Skogh T, Rönnelid J, Sjöwall C.

Clin Exp Immunol. 2019 Nov 28. doi: 10.1111/cei.13402. [Epub ahead of print]

PMID:
31778219
2.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2020 Jan;106:102340. doi: 10.1016/j.jaut.2019.102340. Epub 2019 Oct 17.

3.

Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.

Martinsson K, Roos Ljungberg K, Ziegelasch M, Cedergren J, Eriksson P, Klimovich V, Reckner Å, Griazeva I, Sjöwall C, Samoylovich M, Skogh T, Wetterö J, Kastbom A.

Rheumatology (Oxford). 2019 Aug 27. pii: kez348. doi: 10.1093/rheumatology/kez348. [Epub ahead of print]

PMID:
31504979
4.

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts.

Frodlund M, Reid S, Wetterö J, Dahlström Ö, Sjöwall C, Leonard D.

Lupus. 2019 Sep;28(10):1261-1272. doi: 10.1177/0961203319860198. Epub 2019 Jul 11.

5.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

6.

Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus.

Appelgren D, Dahle C, Knopf J, Bilyy R, Vovk V, Sundgren PC, Bengtsson AA, Wetterö J, Muñoz LE, Herrmann M, Höög A, Sjöwall C.

Autoimmunity. 2018 Sep;51(6):310-318. doi: 10.1080/08916934.2018.1514496. Epub 2018 Oct 28.

7.

Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.

Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.

Clin Exp Immunol. 2018 Oct;194(1):27-38. doi: 10.1111/cei.13180. Epub 2018 Sep 12.

8.

Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.

Kastbom A, Roos Ljungberg K, Ziegelasch M, Wetterö J, Skogh T, Martinsson K.

Clin Exp Immunol. 2018 Dec;194(3):391-399. doi: 10.1111/cei.13206. Epub 2018 Oct 14.

9.

Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE.

Wirestam L, Frodlund M, Enocsson H, Skogh T, Wetterö J, Sjöwall C.

Lupus Sci Med. 2017 Jul 28;4(1):e000225. doi: 10.1136/lupus-2017-000225. eCollection 2017.

10.

A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus.

Olsson LM, Johansson ÅC, Gullstrand B, Jönsen A, Saevarsdottir S, Rönnblom L, Leonard D, Wetterö J, Sjöwall C, Svenungsson E, Gunnarsson I, Bengtsson AA, Holmdahl R.

Ann Rheum Dis. 2017 Sep;76(9):1607-1613. doi: 10.1136/annrheumdis-2017-211287. Epub 2017 Jun 12.

PMID:
28606963
11.

Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.

Clin Exp Immunol. 2017 Jul;189(1):83-91. doi: 10.1111/cei.12957. Epub 2017 Mar 31.

12.

Circulating cartilage oligomeric matrix protein in juvenile idiopathic arthritis.

Lewander P, Dahle C, Larsson B, Wetterö J, Skogh T.

Scand J Rheumatol. 2017 May;46(3):194-197. doi: 10.1080/03009742.2016.1192681. Epub 2016 Jul 6.

13.

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.

Wirestam L, Schierbeck H, Skogh T, Gunnarsson I, Ottosson L, Erlandsson-Harris H, Wetterö J, Sjöwall C.

Arthritis Res Ther. 2015 Nov 23;17:338. doi: 10.1186/s13075-015-0856-2.

14.

Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus.

Björk M, Dahlström Ö, Wetterö J, Sjöwall C.

BMC Musculoskelet Disord. 2015 Aug 12;16:188. doi: 10.1186/s12891-015-0621-3.

15.

Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?

Enocsson H, Sjöwall C, Wetterö J.

Clin Chim Acta. 2015 Apr 15;444:234-41. doi: 10.1016/j.cca.2015.02.031. Epub 2015 Feb 19. Review.

16.

Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity.

Enocsson H, Sjöwall C, Wirestam L, Dahle C, Kastbom A, Rönnelid J, Wetterö J, Skogh T.

J Rheumatol. 2015 May;42(5):817-25. doi: 10.3899/jrheum.140677. Epub 2015 Feb 15.

17.

Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.

Enocsson H, Sjöwall C, Kastbom A, Skogh T, Eloranta ML, Rönnblom L, Wetterö J.

Arthritis Rheumatol. 2014 Jun;66(6):1568-73. doi: 10.1002/art.38408.

18.

Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.

Enocsson H, Wetterö J, Skogh T, Sjöwall C.

Transl Res. 2013 Nov;162(5):287-96. doi: 10.1016/j.trsl.2013.07.003. Epub 2013 Aug 1.

PMID:
23916811
19.

C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.

Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA.

Autoimmunity. 2013 May;46(3):205-14. doi: 10.3109/08916934.2013.764992. Epub 2013 Feb 25.

PMID:
23331132
20.

C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood.

Skoglund C, Wetterö J, Bengtsson T.

Immunol Lett. 2012 Feb 29;142(1-2):28-33. doi: 10.1016/j.imlet.2011.11.003. Epub 2011 Nov 28.

PMID:
22142906
21.

Cell expansion of human articular chondrocytes on macroporous gelatine scaffolds-impact of microcarrier selection on cell proliferation.

Pettersson S, Wetterö J, Tengvall P, Kratz G.

Biomed Mater. 2011 Dec;6(6):065001. doi: 10.1088/1748-6041/6/6/065001. Epub 2011 Sep 29.

PMID:
21959554
22.

IgG rheumatoid factors against the four human Fc-gamma subclasses in early rheumatoid arthritis (the Swedish TIRA project).

Kanmert D, Kastbom A, Almroth G, Skogh T, Enander K, Wetterö J.

Scand J Immunol. 2012 Jan;75(1):115-9. doi: 10.1111/j.1365-3083.2011.02626.x.

23.
24.

C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.

Skoglund C, Wetterö J, Tengvall P, Bengtsson T.

Immunobiology. 2010 Dec;215(12):987-95. doi: 10.1016/j.imbio.2009.11.004. Epub 2010 Feb 16.

25.

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.

Sjöwall C, Zickert A, Skogh T, Wetterö J, Gunnarsson I.

Arthritis Res Ther. 2009;11(6):R188. doi: 10.1186/ar2880. Epub 2009 Dec 11.

26.

Designed surface with tunable IgG density as an in vitro model for immune complex mediated stimulation of leukocytes.

Kanmert D, Enocsson H, Wetterö J, Kastbom A, Skogh T, Enander K.

Langmuir. 2010 Mar 2;26(5):3493-7. doi: 10.1021/la9030766.

PMID:
20000861
27.

Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?

Enocsson H, Sjöwall C, Skogh T, Eloranta ML, Rönnblom L, Wetterö J.

Arthritis Rheum. 2009 Dec;60(12):3755-60. doi: 10.1002/art.25042.

28.

Human articular chondrocytes on macroporous gelatin microcarriers form structurally stable constructs with blood-derived biological glues in vitro.

Pettersson S, Wetterö J, Tengvall P, Kratz G.

J Tissue Eng Regen Med. 2009 Aug;3(6):450-60. doi: 10.1002/term.179.

PMID:
19444864
29.

Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome.

Wetterö J, Nilsson L, Jonasson L, Sjöwall C.

Clin Chim Acta. 2009 Feb;400(1-2):128-31. doi: 10.1016/j.cca.2008.10.002. Epub 2008 Oct 17.

PMID:
18973750
30.

Simultaneous use of electrochemistry and chemiluminescence to detect reactive oxygen species produced by human neutrophils.

Shleev S, Wetterö J, Magnusson KE, Ruzgas T.

Cell Biol Int. 2008 Dec;32(12):1486-96. doi: 10.1016/j.cellbi.2008.08.016. Epub 2008 Aug 20.

PMID:
18782628
31.

Immobilized chemoattractant peptides mediate adhesion and distinct calcium-dependent cell signaling in human neutrophils.

Wetterö J, Hellerstedt T, Nygren P, Broo K, Aili D, Liedberg B, Magnusson KE.

Langmuir. 2008 Jun 1;24(13):6803-11. doi: 10.1021/la703502y. Epub 2008 May 29.

PMID:
18507416
32.

C-reactive protein and C1q regulate platelet adhesion and activation on adsorbed immunoglobulin G and albumin.

Skoglund C, Wetterö J, Skogh T, Sjöwall C, Tengvall P, Bengtsson T.

Immunol Cell Biol. 2008 Jul;86(5):466-74. doi: 10.1038/icb.2008.9. Epub 2008 Mar 11.

PMID:
18332893
33.

Surface plasmon resonance detection of blood coagulation and platelet adhesion under venous and arterial shear conditions.

Hansson KM, Johansen K, Wetterö J, Klenkar G, Benesch J, Lundström I, Lindahl TL, Tengvall P.

Biosens Bioelectron. 2007 Sep 30;23(2):261-8. Epub 2007 May 4.

PMID:
17548188
34.

Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.

Sjöwall C, Wetterö J.

Clin Chim Acta. 2007 Mar;378(1-2):13-23. Epub 2006 Dec 13. Review.

PMID:
17239838
35.

Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.

Sjöwall C, Wetterö J, Bengtsson T, Askendal A, Almroth G, Skogh T, Tengvall P.

Biochem Biophys Res Commun. 2007 Jan 5;352(1):251-8. Epub 2006 Nov 13.

PMID:
17113035
36.

Role of the actin cytoskeleton during respiratory burst in chemoattractant-stimulated neutrophils.

Bengtsson T, Orselius K, Wetterö J.

Cell Biol Int. 2006 Feb;30(2):154-63. Epub 2006 Jan 30.

PMID:
16448823
37.

Electrochemical characterization and application of azurin-modified gold electrodes for detection of superoxide.

Shleev S, Wetterö J, Magnusson KE, Ruzgas T.

Biosens Bioelectron. 2006 Aug 15;22(2):213-9. Epub 2006 Jan 25.

PMID:
16442792
38.

Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces.

Hansson KM, Tosatti S, Isaksson J, Wetterö J, Textor M, Lindahl TL, Tengvall P.

Biomaterials. 2005 Mar;26(8):861-72.

PMID:
15353197
39.

Oxygen radical production in neutrophils interacting with platelets and surface-immobilized plasma proteins: role of tyrosine phosphorylation.

Nimeri G, Majeed M, Elwing H, Ohman L, Wetterö J, Bengtsson T.

J Biomed Mater Res A. 2003 Nov 1;67(2):439-47.

PMID:
14566784
40.

Interactions between surface-bound actin and complement, platelets, and neutrophils.

Wetterö J, Askendal A, Tengvall P, Bengtsson T.

J Biomed Mater Res A. 2003 Jul 1;66(1):162-75.

PMID:
12833443
41.

Platelets stimulated by IgG-coated surfaces bind and activate neutrophils through a selectin-dependent pathway.

Wetterö J, Tengvall P, Bengtsson T.

Biomaterials. 2003 Apr;24(9):1559-73.

PMID:
12559816
42.
43.

On the binding of complement to solid artificial surfaces in vitro.

Wetterö J, Askendal A, Bengtsson T, Tengvall P.

Biomaterials. 2002 Feb;23(4):981-91.

PMID:
11791932
44.

C1q-independent activation of neutrophils by immunoglobulin M-coated surfaces.

Wetterö J, Bengtsson T, Tengvall P.

J Biomed Mater Res. 2001 Dec 15;57(4):550-8.

PMID:
11553885
45.

Supplemental Content

Loading ...
Support Center